Suppr超能文献

[脏层胸膜侵犯对Ⅰb期非小细胞肺癌预后的影响]

[Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].

作者信息

Su Xiao-Dong, Long Hao, Wang Xin, Fu Jian-Hua, He Jie-Hua, Lin Peng, Zhang Lan-Jun, Ma Guo-Wei

机构信息

State Key Laboratory of Oncology in Southern China, Lung Cancer Research Center, Department of Thoracic Surgery, Sun Yet-Sen University, Guangzhou 510060, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):368-71.

Abstract

OBJECTIVE

To investigate the impact of visceral pleural invasion (VPI) on prognosis and staging in patients with stage Ib non-small cell lung cancer (NSCLC).

METHODS

Clinical data of 232 patients with stage Ib NSCLC surgically treated by curative resection between January 1994 and December 2003 was retrospectively reviewed. Histopathological diagnosis was reviewed by an experienced pathologist. According to the tumor size and status of VPI, patients were stratified into three group: group A: tumor > 3 cm and VPI(-); group B: tumor < or = 3 cm and VPI (+); group C: tumor > 3 cm and VPI(+). There were 45 patients in group A, 96 in group B and 91 in group C. Kaplan-Meier method was used for survival analysis. Cox proportional hazards model was used for multivariate analysis.

RESULTS

187 (80.6%) patients had visceral plural invasion, while 45 (19.4%) had no. The 5-and 10-year survival rates of patients with VPI were 59.3% and 42.6%, while it was 70.1% and 56.7% for the patients without (P = 0.035), respectively. The 5-year survival rates of patients in group A, B and C were 70.1%, 61.9% and 56.2%; and 10-years survival rates were 56.7%, 50.6% and 35.9%, respectively (P = 0.018). VPI with large size of tumor was revealed by Cox multivariate analysis as an independent prognostic factor (RR = 1.530, 95% CI: 1.132-2.067, P = 0.006).

CONCLUSION

A significant difference in survival exists among the stage Ib NSCLC patients who have different T status, the patient with > 3 cm tumor and visceral plural invasion may have the worst prognosis. Further studies are still needed to assess whether it is necessary or not to modify the T2 statue of tumor > 3 cm with visceral plural invasion.

摘要

目的

探讨脏层胸膜侵犯(VPI)对Ib期非小细胞肺癌(NSCLC)患者预后及分期的影响。

方法

回顾性分析1994年1月至2003年12月间232例行根治性手术切除的Ib期NSCLC患者的临床资料。由经验丰富的病理学家复查组织病理学诊断。根据肿瘤大小及VPI状态,将患者分为三组:A组:肿瘤>3 cm且VPI(-);B组:肿瘤≤3 cm且VPI(+);C组:肿瘤>3 cm且VPI(+)。A组45例,B组96例,C组91例。采用Kaplan-Meier法进行生存分析,Cox比例风险模型进行多因素分析。

结果

187例(80.6%)患者存在脏层胸膜侵犯,45例(19.4%)无脏层胸膜侵犯。有VPI患者的5年和10年生存率分别为59.3%和42.6%,无VPI患者分别为70.1%和56.7%(P = 0.035)。A、B、C组患者的5年生存率分别为70.1%、61.9%和56.2%;10年生存率分别为56.7%、50.6%和35.9%(P = 0.018)。Cox多因素分析显示肿瘤体积大伴VPI是独立的预后因素(RR = 1.53 , 95% CI:1.132 - 2.067 , P = 0.006)。

结论

不同T状态的Ib期NSCLC患者生存存在显著差异,肿瘤>3 cm且有脏层胸膜侵犯的患者预后可能最差。是否有必要修改肿瘤>3 cm且有脏层胸膜侵犯的T2分期仍需进一步研究评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验